Mice with GNAO1 R209H Movement Disorder Variant Display Hyperlocomotion Alleviated by Risperidone.

Larrivee CL, Feng H, Quinn JA, Shaw VS, Leipprandt JR, Demireva EY, Xie H, Neubig RR.

J Pharmacol Exp Ther. 2020 Apr;373(1):24-33. doi: 10.1124/jpet.119.262733. Epub 2020 Jan 6.

Movement disorders in patients with alternating hemiplegia: "Soft" and "stiff" at the same time.

Panagiotakaki E, Doummar D, Nogue E, Nagot N, Lesca G, Riant F, Nicole S, Delaygue C, Barthez MA, Nassogne MC, Dusser A, Vallée L, Billette T, Bourgeois M, Ioos C, Gitiaux C, Laroche C, Milh M, Portes

Neurology. 2020 Mar 31;94(13):e1378-e1385. doi: 10.1212/WNL.0000000000009175. Epub 2020 Mar 2.

POLR3A variants with striatal involvement and extrapyramidal movement disorder.

Harting I, Al-Saady M, Krägeloh-Mann I, Bley A, Hempel M, Bierhals T, Karch S, Moog U, Bernard G, Huntsman R, van Spaendonk RML, Vreeburg M, Rodríguez-Palmero A, Pujol A, van der Knaap MS, Pouwels PJW

Neurogenetics. 2020 Apr;21(2):121-133. doi: 10.1007/s10048-019-00602-4. Epub 2020 Jan 15.

Movement Disorder in Copper Toxicity Rat Model: Role of Inflammation and Apoptosis in the Corpus Striatum.

Kalita J, Kumar V, Misra UK, Bora HK.

Neurotox Res. 2020 Apr;37(4):904-912. doi: 10.1007/s12640-019-00140-9. Epub 2019 Dec 6.

Treatable Movement Disorders of Infancy and Early Childhood.

Aravamuthan BR, Pearson TS.

Semin Neurol. 2020 Apr;40(2):177-191. doi: 10.1055/s-0040-1702938. Epub 2020 Feb 20.

Future of Tanscranial Magnetic Stimulation in Movement Disorders: Introduction of Novel Methods.

Ugawa Y, Shimo Y, Terao Y.

J Mov Disord. 2020 Apr 6. doi: 10.14802/jmd.19083. [Epub ahead of print]

Whole exome sequencing identifies a homozygous POLG2 missense variant in an adult patient presenting with optic atrophy, movement disorders, premature ovarian failure and mitochondrial DNA depletion.

Dosekova P, Dubiel A, Karlowicz A, Zietkiewicz S, Rydzanicz M, Habalova V, Pienkowski VM, Skirkova M, Han V, Mosejova A, Gdovinova Z, Kaliszewska M, Tońska K, Szymanski MR, Skorvanek M, Ploski R.

Eur J Med Genet. 2020 Apr;63(4):103821. doi: 10.1016/j.ejmg.2019.103821. Epub 2019 Nov 26.

Truncating mutations in YIF1B cause a progressive encephalopathy with various degrees of mixed movement disorder, microcephaly, and epilepsy.

AlMuhaizea M, AlMass R, AlHargan A, AlBader A, Medico Salsench E, Howaidi J, Ihinger J, Karachunski P, Begtrup A, Segura Castell M, Bauer P, Bertoli-Avella A, Kaya IH, AlSufayan J, AlQuait L, Chedrawi

Acta Neuropathol. 2020 Apr;139(4):791-794. doi: 10.1007/s00401-020-02128-8. Epub 2020 Jan 31. No abstract available.

Relationship of Movement Disorders Society-Unified Parkinson's Disease Rating Scale Nonmotor Symptoms to Cognitive Functioning in Patients with Parkinson's Disease.

Bernard BA, Carns D, Stebbins GT, Goldman JG, Goetz CG.

Mov Disord Clin Pract. 2020 Feb 12;7(3):279-283. doi: 10.1002/mdc3.12902. eCollection 2020 Apr.

[Movement Disorders: What Are You Doing? What Can We Do?]

Oertel MF, Baumann CR, Stieglitz LH.

Praxis (Bern 1994). 2020 Apr;109(6):433-437. doi: 10.1024/1661-8157/a003422. German.

Isolated mandibular sleep-related rhythmic movement disorder: A case report.

Roethlisberger SC, Zubler F.

Cranio. 2020 Apr 3:1-3. doi: 10.1080/08869634.2020.1747715. [Epub ahead of print]

Emergency presentations of movement disorders.

Gandhi SE, Newman EJ, Marshall VL.

Pract Neurol. 2020 Apr 16. pii: practneurol-2019-002277. doi: 10.1136/practneurol-2019-002277. [Epub ahead of print] Review.

A "Neuromuscular Look" to sarcopenia: Is it a movement disorder?

Kara M, Özçakar L, Kaymak B, Ata AM, Frontera W.

J Rehabil Med. 2020 Apr 14;52(4):jrm00042. doi: 10.2340/16501977-2672.

A homozygous MRPL24 mutation causes a complex movement disorder and affects the mitoribosome assembly.

Nottia MD, Marchese M, Verrigni D, Mutti C, Torraco A, Oliva R, Fernandez-Vizarra E, Morani F, Trani G, Rizza T, Ghezzi D, Ardissone A, Nesti C, Vasco G, Zeviani M, Minczuk M, Bertini E, Santorelli FM

Neurobiol Dis. 2020 Apr 25:104880. doi: 10.1016/j.nbd.2020.104880. [Epub ahead of print]

Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders.

Papa SM, Brundin P, Fung VSC, Kang UJ, Burn DJ, Colosimo C, Chiang HL, Alcalay RN, Trenkwalder C; and the MDS-Scientific Issues Committee..

Mov Disord. 2020 Apr 6. doi: 10.1002/mds.28067. [Epub ahead of print] No abstract available.